{"title":"Generation of Retinal Ganglion Cells from Reprogrammed Keratocytes of Non-Glaucoma and Glaucoma Donors.","authors":"Shahna S Hameed, Tasneem P Sharma","doi":"10.1002/cpz1.70091","DOIUrl":null,"url":null,"abstract":"<p><p>Human induced pluripotent stem cell (hiPSC)-based disease modeling can be successfully recapitulated to mimic disease characteristics across various human pathologies. Glaucoma, a progressive optic neuropathy, primarily affects the retinal ganglion cells (RGCs). While multiple groups have successfully generated RGCs from non-diseased hiPSCs, producing RGCs from glaucomatous human samples holds significant promise for understanding disease pathology by revealing patient-specific disease signatures. Given that keratocytes originate from the neural crest and previous reports suggest that ocular fibroblasts from glaucomatous donors carry pathogenic signatures, it is highly plausible that these signatures imprinted within the keratocytes will also be present in the derived RGCs. Thus, we aimed to generate RGCs from both glaucomatous and non-glaucomatous donor keratocytes and validate disease-specific signatures in 3D retinal organoids and in isolated RGCs. Our protocol describes the generation of iPSCs from keratocytes of both glaucomatous and non-glaucomatous donors, followed by their differentiation into retinal organoids. Subsequent isolation and culturing of RGCs were performed. Disease signatures in the RGCs were validated in both 3D retinal organoids (ROs) and 2D RGC cultures, and glaucomatous RGCs in 3D and 2D cultures demonstrated increased cleaved CASP3 and significant RGC loss, indicating disease imprints in the hiPSC-derived RGCs. This model offers a venue and high throughput platform for studying glaucomatous disease pathology and holds significant potential for drug discovery using RGCs derived from human donors. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Culturing of keratocytes from human cadaveric donors Basic Protocol 2: Reprogramming donor keratocytes into iPSCs Basic Protocol 3: Evaluation of chromosomal loss during reprogramming in iPSCs by karyotyping Basic Protocol 4: Generation of 3D ROs Basic Protocol 5: Dissociation and culturing of RGCs from 3D ROs Support Protocol 1: Immunostaining for phenotypic characterization of cells Support Protocol 2: Sectioning of 3D ROs and immunostaining Support Protocol 3: Western blotting for cleaved CASP3 and THY1.</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 1","pages":"e70091"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11713219/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/cpz1.70091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Human induced pluripotent stem cell (hiPSC)-based disease modeling can be successfully recapitulated to mimic disease characteristics across various human pathologies. Glaucoma, a progressive optic neuropathy, primarily affects the retinal ganglion cells (RGCs). While multiple groups have successfully generated RGCs from non-diseased hiPSCs, producing RGCs from glaucomatous human samples holds significant promise for understanding disease pathology by revealing patient-specific disease signatures. Given that keratocytes originate from the neural crest and previous reports suggest that ocular fibroblasts from glaucomatous donors carry pathogenic signatures, it is highly plausible that these signatures imprinted within the keratocytes will also be present in the derived RGCs. Thus, we aimed to generate RGCs from both glaucomatous and non-glaucomatous donor keratocytes and validate disease-specific signatures in 3D retinal organoids and in isolated RGCs. Our protocol describes the generation of iPSCs from keratocytes of both glaucomatous and non-glaucomatous donors, followed by their differentiation into retinal organoids. Subsequent isolation and culturing of RGCs were performed. Disease signatures in the RGCs were validated in both 3D retinal organoids (ROs) and 2D RGC cultures, and glaucomatous RGCs in 3D and 2D cultures demonstrated increased cleaved CASP3 and significant RGC loss, indicating disease imprints in the hiPSC-derived RGCs. This model offers a venue and high throughput platform for studying glaucomatous disease pathology and holds significant potential for drug discovery using RGCs derived from human donors. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Culturing of keratocytes from human cadaveric donors Basic Protocol 2: Reprogramming donor keratocytes into iPSCs Basic Protocol 3: Evaluation of chromosomal loss during reprogramming in iPSCs by karyotyping Basic Protocol 4: Generation of 3D ROs Basic Protocol 5: Dissociation and culturing of RGCs from 3D ROs Support Protocol 1: Immunostaining for phenotypic characterization of cells Support Protocol 2: Sectioning of 3D ROs and immunostaining Support Protocol 3: Western blotting for cleaved CASP3 and THY1.
从非青光眼和青光眼供体的重编程角化细胞生成视网膜神经节细胞。
基于人类诱导多能干细胞(hiPSC)的疾病建模可以成功地再现以模拟各种人类病理的疾病特征。青光眼是一种进行性视神经病变,主要影响视网膜神经节细胞(RGCs)。虽然多个研究小组已经成功地从未患病的hipsc中生成了RGCs,但通过揭示患者特异性疾病特征,从青光眼人类样本中生成RGCs对于理解疾病病理具有重要意义。鉴于角化细胞来源于神经嵴,先前的报道表明来自青光眼供体的眼成纤维细胞携带致病特征,因此角化细胞内的这些特征也可能存在于衍生的RGCs中。因此,我们旨在从青光眼和非青光眼供体角膜细胞中生成RGCs,并在3D视网膜类器官和分离的RGCs中验证疾病特异性特征。我们的方案描述了从青光眼和非青光眼供体的角化细胞中产生iPSCs,然后将其分化为视网膜类器官。随后进行RGCs的分离和培养。在3D视网膜类器官(ROs)和2D RGC培养中验证了RGC中的疾病特征,3D和2D培养中的青光眼RGC显示出cleaved CASP3增加和显著的RGC丢失,表明hipsc衍生的RGC中存在疾病印记。该模型为研究青光眼疾病病理学提供了一个场所和高通量平台,并具有利用来自人类供体的RGCs进行药物开发的巨大潜力。©2025作者。目前由Wiley期刊有限责任公司发布的方案。基本方案1:从人尸体供体中培养角质细胞基本方案2:将供体角质细胞重编程为iPSCs基本方案3:通过核型分析iPSCs重编程过程中染色体丢失的评估基本方案4:3D ROs的产生基本方案5:从3D ROs中分离和培养rgc支持方案1:细胞表型表征的免疫染色支持方案2:3D ROs切片和免疫染色支持方案3:裂解CASP3和THY1的Western blotting。
本文章由计算机程序翻译,如有差异,请以英文原文为准。